| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |